Opinion 26 Apr 2023
Can mRNA vaccines tackle multiple diseases?
By Dr. Myriam Mendila, chief development officer of CureVac World Immunization Week is April 24-30, and it’s an important week…
Curevac
- Latest Posts
In Depth 4 Jul 2022
The COVID-19 pandemic has driven RNA therapeutics into the mainstream
As messenger RNA vaccines save lives around the world, and RNA interference drugs are greenlit for rare diseases, the field…
News and Trends 15 Feb 2022
Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to healthcare systems worldwide. Numerous treatments…
Best in Biotech 20 Dec 2021
The Billion-Euro European Biotech Companies in 2022
Here’s a list of the public European biotech companies that are worth more than a billion euros in 2022. European…
ADVERTISEMENT
Best in Biotech 11 Jan 2021
The 21 European Biotech Companies To Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list of 21 European biotech companies…
Best in Biotech 28 Dec 2020
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at…
News and Trends 17 Aug 2020
CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO
The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced a Nasdaq IPO at €180M…
News and Trends 23 Jul 2020
Pharma Giant GSK and mRNA Biotech CureVac Ink €1B Deal
GlaxoSmithKline (GSK) has struck a deal worth up to €1B with the German biotechnology company CureVac to co-develop messenger RNA…
News and Trends 17 Jun 2020
German Government Invests €300M in mRNA Biotech CureVac
The Federal Republic of Germany will invest €300M in CureVac, the homegrown biotech that is developing a vaccine for Covid-19…
News and Trends 29 Apr 2020
Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans
Update (29/04/2020): A vaccine developed by the German company BioNTech and its big pharma partner Pfizer has become the first…
In Depth 30 Mar 2020
Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
The first vaccine against coronavirus disease could one day be made of mRNA. How is mRNA showing promise against the…
News and Trends 17 Mar 2020
CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute
The German biotech CureVac -- which is developing an mRNA vaccine against coronavirus -- has been granted up to €80M…
News and Trends 3 Feb 2020
CureVac Bids to Develop First mRNA Coronavirus Vaccine
RNA vaccine developer CureVac will receive a grant of up to €8.3M from a global partnership to develop an mRNA…
News and Trends 1 Mar 2019
Rapid Response mRNA Vaccine Facility Gets €30M Funding
An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development grant to rapidly manufacture vaccines…
News and Trends 11 Dec 2018
What Does the Largest Biotech IPO Ever Mean for European Biotech?
With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The news could give a significant…
Best in Biotech 20 Feb 2018
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where many of us re-examine our…
ADVERTISEMENT
Best in Biotech 28 Dec 2017
Bored Between the Holidays? Watch these Biotech Videos!
Christmas might have passed, but we have more videos for you to watch on a dreary winter day! Here are…
Best in Biotech 12 Dec 2017
Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017
As 2016 was a tough year for biotech, 2017 was under pressure to turn things around. Although there has been…
Interview 6 Nov 2017
Battle of the Biotech Unicorns: CureVac vs. Moderna
An interview never seen before. We brought together the founders and CEOs of the two biotech unicorns pioneering mRNA therapy:…
News and Trends 18 Oct 2017
Eli Lilly Offers German Biotech up to €1.5Bn to Develop mRNA Cancer Vaccines
CureVac will be working with pharma giant Eli Lilly in the development of up to five cancer vaccines based on…
